MENU
ANIX
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Anixa Biosciences (ANIX) Ownership - Who owns Anixa Biosciences?

Profile

Industry
Computer Peripherals
Address
3150 Almaden Expressway
Phone
+1 408 708-9808
Employees
5
Web
https://www.anixa.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
101.37M
P/E Ratio
N/A
Total Cash
23.24M
Projected Growth
N/A
Total Debt
149K
Revenue
N/A
Risk (Beta)
0.21
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ANIX
Capitalization
101M
P/E Ratio
N/A
Risk (Beta)
0.21
Dividend Yield
N/A
Total Cash
23.2M
Total Cash/Share
0.72
Total Debt
149K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
23.6M
P/B Ratio
4.66
Cash Flow
N/A
Earnings
-0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
320K
Current Ratio
14.40
Current Revenue Per Employee
42000.00
Dividends Per Share - Security
N/A
EBITDA
-12.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
23.33
Revenue To Assets
-44.64
Shares Held By Institutions
18.4M
Shares Outstanding - Current
32.2M
Total Liabilities
1.77M
Total Volume MTD
N/A
Value
-1
Gain YTD
-21.134
View a ticker or compare two or three
ANIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of non-invasive blood tests for the early detection of solid tumor based cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
3150 Almaden Expressway
Phone
+1 408 708-9808
Employees
5
Web
https://www.anixa.com